James Budge Sells 781 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) CFO James Budge sold 781 shares of Hinge Health stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $55.34, for a total value of $43,220.54. Following the completion of the transaction, the chief financial officer owned 451,293 shares in the company, valued at $24,974,554.62. This represents a 0.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Budge also recently made the following trade(s):

• On Monday, May 11th, James Budge sold 5,906 shares of Hinge Health stock. The stock was sold at an average price of $54.82, for a total value of $323,766.92.
• On Monday, March 23rd, James Budge sold 11,006 shares of Hinge Health stock. The stock was sold at an average price of $42.26, for a total value of $465,113.56.

Hinge Health Price Performance

Hinge Health stock opened at $55.10 on Friday. The stock has a market capitalization of $4.26 billion and a price-to-earnings ratio of -4.46. Hinge Health Inc. has a 1-year low of $30.08 and a 1-year high of $62.18. The business has a fifty day moving average price of $45.04 and a 200-day moving average price of $44.43.

Hinge Health (NYSE:HNGE) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. The firm had revenue of $182.31 million during the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The firm’s revenue for the quarter was up 47.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.30 EPS. On average, equities research analysts anticipate that Hinge Health Inc. will post 1.21 earnings per share for the current fiscal year.

Institutional Trading of Hinge Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wells Fargo & Company MN lifted its position in Hinge Health by 160.0% during the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after acquiring an additional 336 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in Hinge Health during the 4th quarter worth about $26,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Hinge Health during the 3rd quarter worth about $37,000. CENTRAL TRUST Co acquired a new stake in Hinge Health during the 1st quarter worth about $37,000. Finally, First Horizon Corp lifted its position in Hinge Health by 163.9% during the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after acquiring an additional 531 shares during the period.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Wells Fargo & Company raised their price objective on Hinge Health from $68.00 to $80.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Canaccord Genuity Group raised their price objective on Hinge Health from $53.00 to $63.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Wall Street Zen raised Hinge Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Evercore reissued an “outperform” rating and issued a $45.00 price objective on shares of Hinge Health in a research report on Wednesday, April 8th. Finally, Truist Financial set a $79.00 price target on Hinge Health in a research report on Wednesday, May 6th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $67.40.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.